A randomized phase II trial of pre-operative docetaxel and cisplatin (DP) or docetaxel alone (D) in clinical (c-) stage IB/II nonsmall cell lung cancer (NSCLC): Initial report of Japan Clinical Oncology Group trial (JCOG 0204)

被引：0
|
作者：
Tada, H
Katoh, H
Kunitoh, H
Tsuboi, M
Asamura, H
Nagai, K
Mitsudomi, T
Koike, T
Ishizuka, N
Saijoh, N
机构：
[1] Osaka City Gen Hosp, Osaka, Japan
[2] Tokyo Med Coll, Tokyo 160, Japan
[3] Natl Canc Ctr, Tokyo 104, Japan
[4] Natl Canc Ctr E, Kashiwa, Chiba, Japan
[5] Niigata Canc Ctr, Niigata, Japan
[6] Aichi Canc Ctr, Nagoya, Aichi 464, Japan
[7] Int Med Ctr Japan, Tokyo, Japan
[8] Natl Canc Ctr E, Kashiwa, Chiba, Japan
来源：
LUNG CANCER | 2005年 / 49卷
关键词：
D O I：
10.1016/S0169-5002(05)80175-8
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S17 / S17
页数：1
相关论文
共 50 条
  • [31] Survival update in randomized phase II trial of S-1/cisplatin (SP) or docetaxel/cisplatin (DP) with concurrent thoracic radiotherapy for inoperable stage III non-small cell lung cancer (NSCLC)-TORG1018
    Takiguchi, Y.
    Yamada, K.
    Tanaka, H.
    Kubota, K.
    Kishi, K.
    Shimokawa, T.
    Saito, H.
    Hosomi, Y.
    Kato, T.
    Nogami, N.
    Igawa, S.
    Kasai, T.
    Nakamura, Y.
    Yamanaka, T.
    Okamoto, H.
    ANNALS OF ONCOLOGY, 2018, 29
  • [32] A randomized phase II feasibility study of adjuvant cisplatin/docetaxel (CisD) or cisplatin/vinorelbine (CisV) in patients (pts) resected stage IB-II non-small cell lung cancer (NSCLC): Interim analysis
    Galdermans, D.
    Driesen, P.
    Bustin, F.
    Lambrechts, M.
    Deschepper, K.
    Stappaerts, I.
    Verresen, D.
    Janssens, A.
    Germonpre, P. R.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [33] Randomized phase II trial of two sequential schedules of docetaxel (D) and cisplatin (C) followed by gemcitabine (G) in patients with advanced non-small cell lung cancer
    Galligioni, E.
    Gebbia, V.
    Carteni, G.
    Gamucci, T.
    Grossi, F.
    Ferrau, F.
    Nardi, M.
    Pollera, C.
    Rossi, S.
    De Marinis, F.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [34] Docetaxel (D) and vinorelbine (V) in non-small cell lung cancer (NSCLC) previously treated with cisplatin-based chemotherapy:: A phase II trial.
    Muñoz, A
    Rubio, I
    Mañé, JM
    Ferreiro, J
    Fernández, R
    Fuente, N
    Abón, G
    López-Argumedo, G
    Barceló, R
    Vivanco, GL
    ANNALS OF ONCOLOGY, 2000, 11 : 117 - 117
  • [35] RANDOMIZED PHASE II TRIAL OF CARBOPLATIN COMBINED WITH WEEKLY PACLITAXEL (CWP) AND DOCETAXEL ALONE (D) IN ELDERLY PATIENTS WITH ADVANCED NON-SMALL-CELL LUNG CANCER (NSCLC): NJLCG 0801
    Inoue, A.
    Maemondo, M.
    Sugawara, S.
    Harada, T.
    Minegishi, Y.
    Usui, K.
    Ando, M.
    Morikawa, N.
    Mori, Y.
    Ishimoto, O.
    Matsubara, N.
    Sakakibara, T.
    Watanabe, K.
    Gemma, A.
    Nukiwa, T.
    ANNALS OF ONCOLOGY, 2012, 23 : 31 - 31
  • [36] Feasibility of adjuvant carboplatin/docetaxel (C/D) in patients (pts) resected stage I-IIIB non-small cell lung cancer (NSCLC): Preliminary report of a phase II trial
    Stinchcombe, T. E.
    Socinski, M. A.
    Harper, H. D.
    Hensing, T. A.
    Moore, D.
    Crane, J. M.
    Atkins, J. N.
    Willard, E. M.
    Tynan, M. T.
    Gulino, S. E.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [37] Feasibility of Adjuvant carboplatin/docetaxel (C/D) in patients (pts) resected stage I-IIIB non-small cell lung cancer (NSCLC): Preliminary report of a phase II trial
    Stinchcombe, Thomas E.
    Socinski, Mark A.
    Harper, Harry D.
    Hensing, Thomas A.
    Moore, Dominic T.
    Crane, Jeffrey
    Atkins, James N.
    Willard, Ellen M.
    Tynan, Maureen T.
    Gulino, Sara E.
    JOURNAL OF THORACIC ONCOLOGY, 2007, 2 (08) : S453 - S453
  • [38] Phase II study of cisplatin and 5-fluorouracil with concurrent radiotherapy in advanced squamous cell carcinoma of the esophagus: a Japan esophageal oncology group (JEOG)/Japan clinical oncology group trial (JCOG9516)
    Ishida, K
    Ando, N
    Yamamoto, S
    Ide, H
    Shinoda, M
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2004, 34 (10) : 615 - 619
  • [39] A phase I/II clinical trial of intravenous (IV) calcitriol with fixed doses of cisplatin and docetaxel in advanced non-small cell lung cancer.
    Ramnath, Nithya
    Daignault-Newton, Stephanie
    Dy, Grace K.
    Muindi, Josephia
    Adjei, Araba
    Kalemkerian, Gregory Peter
    Cease, Kemp Bailey
    Stella, Philip J.
    Brenner, Dean E.
    Johnson, Candace S.
    Trump, Donald L.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [40] Randomized phase II study of chemoradiotherapy with versus without induction chemotherapy for locally advanced pancreatic cancer: Japan Clinical Oncology Group trial, JCOG1106
    Ioka, Tatsuya
    Furuse, Junji
    Fukutomi, Akira
    Mizusawa, Junki
    Nakamura, Satoaki
    Hiraoka, Nobuyoshi
    Ito, Yoshinori
    Katayama, Hiroshi
    Ueno, Makoto
    Ikeda, Masafumi
    Sugimori, Kazuya
    Okano, Naohiro
    Shimizu, Kyoko
    Yanagimoto, Hiroaki
    Okusaka, Takuji
    Ozaka, Masato
    Todaka, Akiko
    Nakamori, Shoji
    Tobimatsu, Kazutoshi
    Sata, Naohiro
    Kawashima, Yohei
    Hosokawa, Ayumu
    Yamaguchi, Taketo
    Miyakawa, Hiroyuki
    Hara, Hiroki
    Mizuno, Nobumasa
    Ishii, Hiroshi
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2021, 51 (02) : 235 - 243
12345